Skip to content
healthcare.dev

HEPCLUDEX

NDC 61958-3104, BULEVIRTIDE, injection, powder, lyophilized, for solution, from Gilead Sciences, Inc..

Product NDC
61958-3104
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761468
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3104 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BULEVIRTIDE ACETATE8.5 mg/1
Package NDCNDC-11Package
61958-3104-16195831040130 VIAL, SINGLE-DOSE in 1 CARTON (61958-3104-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (61958-3104-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12391cc2-38c2-4cf5-86d3-2be9370127fc

Use it

Look up 61958-3104 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3104 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-3104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.